63 search results found
-
Cellino Biotech, Inc.
Cambridge, MACellino has built the first platform that enables precise control over iPS cell fate in their natural environment. Their proprietary delivery technology, NanoLaze, delivers synthetic biology tools to control the sequence of genes being turned on and off inside a cell. This offers precise, “digital”... More
-
AgTech Workshop 2018 - Welcome
James Gado - Welcome
- Tue, June 20, 2023 | Conference
2023 MIT London Symposium - Startup Exchange Lightning Talks
BT - One Braham (UK)Startup Lightning Talks - 2023 MIT London Symposium: Value, Values, and Future Platforms (9:00AM - 4:15PM)
-
DeepCure Inc.
Boston, MADeepCure develops disruptive Artificial Intelligence technology to revolutionize pharmaceutical development. The pharma industry is undoubtedly one of the world's largest, with worldwide revenues topping one trillion US dollars. However, its effectiveness is in question, as the exponentially... MoreKeywords: -
Past Deadline: Jun 21, 2021
P&G Seeks Startups for 2 Innovation Briefs
partnershipP&G is looking for new approaches and technologies that can help them to address key business challenges/opportunities.
-
DUST Identity
Newton, MADUST -- the Diamond Uncloneable Security Tag -- is a proprietary technology which utilizes nanodiamonds to create an unclonable identity layer on any object. An optical scanner and cloud-based infrastructure provides an interface to the object identity and provenance. DUST ensures that trusted data... MoreKeywords:
-
Cracking Cancer 2.0 - Panel Discussion
Trond Undheim, PhD, Program Director, MIT Startup Exchange; Paula Hammond, PhD, David H. Koch Professor in Engineering and Department Head, Chemical Engineering, MIT; Laura Indolfi, PhD, CEO of PanTher Therapeutics; Peter Sandor, VP, Head of Oncology Marketing Strategy, Astellas.
-
BioBright
Charles Fracchia, Founder, BioBright
-
Past Deadline: Feb 25, 2020
Anglo American seeking startups for February visit
meetingAnglo American, a British mining company, is looking for startups in bio technology, rapid access, improved recovery, dry processing, mining legacy, sensor fusion, and EPC disruption.
-
Kytopen Corporation
Cambridge, MAKytopen is developing platforms to accelerate the discovery and manufacturing of next-generation cell & gene therapies. The Flowfect technology offers a scalable, non-viral solution to deliver genetic payloads to cells in order to augment their functionality. The technology also enables continuous... MoreKeywords:
